Development of clinical trials

  • To develop phase I-II clinical trials based on the results derived from the research on preclinical models and new biomarkers.
  • Clinical trials promoted by our own researchers, as well as within Spanish cooperative groups for the study of hematological malignancies (PETHEMA, GEM, GELTAMO, GETH, etc…) to validate diagnostics studies and biomarkers.
  • To develop and implement an information system that encompasses the processing of Research Projects and Clinical Trials, as well as quality records.


Leading Researcher

Montesinos Fernández, PauLeading Researcher